Inhibition of cyclic gonadotropin secretion by endogenous human prolactin

John E. Tyson, J E Tyson, M. Khojandi, J. Huth, Beverly Smith, B Smith, P. Thomas
American journal of obstetrics and gynecology · 1975 · vol. 121(3) , pp. 375–379 · doi:10.1016/0002-9378(75)90015-0 · PMID:1115151 · W1646486504
Other OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-14 ⓘ

Suppression of endogenous human prolactin with 2-Br-alpha-ergocryptine restored cyclic gonadotropin secretion, ovulation, and menstruation, indicating that prolactin inhibits cyclic rather than tonic gonadotropin release.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The resumption of cyclic uterine bleeding reportedly accompanies the use of human prolactin (HPRL)-suppressing agents in postpill galactorrhea-amenorrhea. In this laboratory, HPRL suppression with L-dopa was variable and short lived. Basal plasma HPRL levels were elevated before and after as much as five months of therapy. Galactorrhea persisted and mean gonadotropin concentrations were subnormal. An immediate and sustained attenuation of HPRL secretion ( less than 200 per cent) followed the use of 2-Br-alpha-ergocryptine (CB-154). Cyclic gonadotropin secretion resumed and was accompanied by ovulation and, in one instance, pregnancy. The cessation of galactorrhea was positively correlated with the rise in the daily concentration of 17 beta-estradiol. Cyclic postovulatory menstruation continued after the cessation of CB-154 treatment. HPRL levels remained normal. The daily patterns of human follicle-stimulating hormone (HFSH) and human tuteinizing hormone (HLH) secretion created by the suppression of HPRL displayed an inherent rhythmicity identical to that observed at the time of menarche. The inhibitory effects of HPRL appeared directed at cyclic rather than tonic gonadotropin secretion. At the same time, diminished ovarian estrogen production seemed to increase mammary gland sensitivity to HPRL, leading to lactation. One may postulate, therefore, that the ingestion of sex steroids is associated with an over-all suppression of endogenous cyclic and, to a lesser extent, tonic gonadotropin secretion secondary to which ovarian function is attenuated. Without physiologic concentration of circulating estrogen, HPRL induces mammary alveolar function with the production of a milklike secretion.

My notes (saved in your browser only)

MeSH descriptors

Gonadotropins Prolactin Amenorrhea Amenorrhea Amenorrhea Bromine Bromine Depression, Chemical Dihydroxyphenylalanine Dihydroxyphenylalanine Ergot Alkaloids Ergot Alkaloids Estradiol Estradiol Estrogens Estrogens Female Follicle Stimulating Hormone Follicle Stimulating Hormone Galactorrhea

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (2)

References (21)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:46.244316+00:00
License: CC0 · commercial use OK